Peripheral and central sensitization during migraine.

Funct Neurol. 2000;15 Suppl 3:28-35.
Links
Peripheral and central sensitization during migraine.
Malick A, Burstein R.
Department of Neurobiology, Program in Neuroscience, Harvard Medical School, Boston, MA, USA.
Current theories propose that the pain of migraine is caused by chemical activation of meningeal perivascular fibers. In an animal model of migraine, we have recently shown that chemical activation of meningeal primary afferent nociceptors that innervate the dura could lead to the following: a) peripheral sensitization of these nociceptors to intracranial mechanical stimulation; b) central sensitization of second-order trigeminovascular neurons that receive convergent input from the dura and skin to extracranial mechanical and thermal stimulation; and c) facilitated cardiovascular pressor responses that are usually indicative of pain. These findings provide the first set of evidence for the induction of peripheral and central sensitization along trigeminovascular pain pathways by visceral input from the intracranial dura. We propose that the throbbing pain of migraine is mediated mainly through peripheral and to a lesser extent through central sensitization, and that the development of scalp tenderness is mediated mainly through central sensitization.
PMID: 11200798 [PubMed - indexed for MEDLINE]
Related articles
Cardiovascular and neuronal responses to head stimulation reflect central sensitization and cutaneous allodynia in a rat model of migraine.
J Neurophysiol. 1999 Feb; 81(2):479-93.
[J Neurophysiol. 1999]
ReviewEffect of nitric oxide donors on the central nervous system--nitroglycerin studies in the rat.
Funct Neurol. 2000; 15 Suppl 3:19-27.
[Funct Neurol. 2000]
Chemical stimulation of the intracranial dura induces enhanced responses to facial stimulation in brain stem trigeminal neurons.
J Neurophysiol. 1998 Feb; 79(2):964-82.
[J Neurophysiol. 1998]
Terminating migraine with allodynia and ongoing central sensitization using parenteral administration of COX1/COX2 inhibitors.
Headache. 2005 Jul-Aug; 45(7):850-61.
[Headache. 2005]
ReviewPeripheral and central activation of trigeminal pain pathways in migraine: data from experimental animal models.
Cephalalgia. 2003; 23 Suppl 1:1-4.
[Cephalalgia. 2003]
» See reviews... » See all...
Cited by 1 PubMed Central article
Review of frovatriptan in the treatment of migraine.
Kelman L. Neuropsychiatr Dis Treat. 2008 Feb; 4(1):49-54.
[Neuropsychiatr Dis Treat. 2008]